FIELD: medicine.
SUBSTANCE: relative content of CD27+ cells in the population of CD19+ B-lymphocytes is determined for women in the period of 32-36 weeks of pregnancy in the peripheral blood. With a value of 19.4% or less, the effectiveness of standard treatment of fetal growth retardation is predicted.
EFFECT: application of the invention provides the accuracy, sensitivity and specificity of forecasting the efficiency of standard treatment of fetal growth retardation that allows to define the tactics of pregnant women treatment and conduct timely measures in the group of women with this pregnancy pathology.
1 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTING FOETAL GROWTH RETARDATION IN WOMEN WITH HIGH-RISK PREMATURE BIRTH | 2023 |
|
RU2806311C1 |
| METHOD FOR PREDICTING EFFECTIVENESS OF TREATMENT OF MODERATE PREECLAMPSIA | 2020 |
|
RU2752715C1 |
| METHOD FOR FETAL GROWTH RESTRICTION PREDICTION | 2020 |
|
RU2738674C1 |
| METHOD OF PREDICTING MENACING PREMATURE BIRTH AT WOMEN WITH THREAT OF MISCARRIAGE OF EARLY TERMS | 2007 |
|
RU2344424C1 |
| METHOD FOR EARLY PREDICTION OF FETAL GROWTH RETARDATION | 2019 |
|
RU2718725C1 |
| METHOD FOR PREDICTING EFFICIENCY IN TREATING FETAL DEVELOPMENT DELAY SYNDROME | 2005 |
|
RU2303958C1 |
| METHOD FOR PREDICTING CLINICAL EFFECTIVENESS IN SEVERE GESTOSES | 2008 |
|
RU2377569C1 |
| METHOD OF PREDICTING EFFICIENCY OF TREATING MISCARRIAGES | 2010 |
|
RU2439571C1 |
| METHOD FOR PREDICTING FETAL GROWTH RETARDATION IN WOMEN WITH GESTATIONAL DIABETES MELLITUS AND THREATENED LATE MISCARRIAGE | 2022 |
|
RU2792757C1 |
| METHOD FOR PREDICTING THE EFFECTIVENESS OF THE TREATMENT OF MODERATE PREECLAMPSIA | 2019 |
|
RU2705374C1 |
